Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

German Ott

Showing results (231-240 of 374) with videos related to

Pageof 38
Sort By:
The Lancet. Haematology|March 5, 2021
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trialFabian Frontzek, Marita Ziepert, Maike Nickelsen, et al.
Blood|April 20, 2021
Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCLAnja Schmitt, Wendan Xu, Philip Bucher, et al.
Frontiers in Immunology|August 21, 2023
Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphomaMaria Patra-Kneuer, Gaomei Chang, Wendan Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2020
A Cyclin D1-Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell LymphomaSantiago Demajo, Robert Albero, Guillem Clot, et al.
International Journal of Cancer|June 15, 2017
TP53 mutation and survival in aggressive B cell lymphomaThorsten Zenz, Markus Kreuz, Maxi Fuge, et al.
Leukemia|January 5, 2023
Molecular profiling of EBV associated diffuse large B-cell lymphomaFabian Frontzek, Annette M Staiger, Ramona Wullenkord, et al.
Genes, Chromosomes & Cancer|September 8, 2007
Frequent occurrence of deletions in primary mediastinal B-cell lymphomaLindsey R Kimm, Ronald J deLeeuw, Kerry J Savage, et al.
Blood|August 22, 2018
Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profilesJohannes C Hellmuth, Abner Louissaint, Monika Szczepanowski, et al.
Blood Advances|March 26, 2026
Immune disparities in the TME of EBV+ and EBV- BL: role of ROS generation pathways and platelet activationMaria Chiara Siciliano, Giorgio Bertolazzi, Selina Glaser, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2013
Related F-box proteins control cell death in Caenorhabditis elegans and human lymphomaMichael Chiorazzi, Lixin Rui, Yandan Yang, et al.
Pageof 38

Showing results (231-240 of 374) with videos related to

Sort By:
Pageof 38
The Lancet. Haematology|March 5, 2021
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trialFabian Frontzek, Marita Ziepert, Maike Nickelsen, et al.
Blood|April 20, 2021
Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCLAnja Schmitt, Wendan Xu, Philip Bucher, et al.
Frontiers in Immunology|August 21, 2023
Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphomaMaria Patra-Kneuer, Gaomei Chang, Wendan Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2020
A Cyclin D1-Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell LymphomaSantiago Demajo, Robert Albero, Guillem Clot, et al.
International Journal of Cancer|June 15, 2017
TP53 mutation and survival in aggressive B cell lymphomaThorsten Zenz, Markus Kreuz, Maxi Fuge, et al.
Leukemia|January 5, 2023
Molecular profiling of EBV associated diffuse large B-cell lymphomaFabian Frontzek, Annette M Staiger, Ramona Wullenkord, et al.
Genes, Chromosomes & Cancer|September 8, 2007
Frequent occurrence of deletions in primary mediastinal B-cell lymphomaLindsey R Kimm, Ronald J deLeeuw, Kerry J Savage, et al.
Blood|August 22, 2018
Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profilesJohannes C Hellmuth, Abner Louissaint, Monika Szczepanowski, et al.
Blood Advances|March 26, 2026
Immune disparities in the TME of EBV+ and EBV- BL: role of ROS generation pathways and platelet activationMaria Chiara Siciliano, Giorgio Bertolazzi, Selina Glaser, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2013
Related F-box proteins control cell death in Caenorhabditis elegans and human lymphomaMichael Chiorazzi, Lixin Rui, Yandan Yang, et al.
Pageof 38